• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-G可上调抗原呈递细胞、自然杀伤细胞和T细胞中的ILT2、ILT3、ILT4和KIR2DL4。

HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.

作者信息

LeMaoult Joël, Zafaranloo Kamélia, Le Danff Caroline, Carosella Edgardo D

机构信息

Service de Recherches en Hémato-Immunologie, Commissariat à L'Energie Atomique-DRM-DSV, Institut Universitaire d'Hématologie, Hôpital Saint Louis, Paris, France.

出版信息

FASEB J. 2005 Apr;19(6):662-4. doi: 10.1096/fj.04-1617fje. Epub 2005 Jan 24.

DOI:10.1096/fj.04-1617fje
PMID:15670976
Abstract

The nonclassical HLA class I antigen HLA-G is an inhibitory molecule involved in immune tolerance and immune escape. HLA-G exerts its inhibitory functions via interaction with inhibitory receptors ILT2, ILT4, and KIR2DL4, differentially expressed by NK, T, and antigen-presenting cells. Cells expressing HLA-G and cells expressing its receptors are often found in the vicinity of each other, but the mechanisms responsible for this colocalization are still unknown. We report that ILT2, ILT3, ILT4, and KIR2DL4 expression is up-regulated by HLA-G in antigen-presenting cells, NK cells, and T cells. Because this up-regulation seems not to require antigenic costimulation, it might precede an immune response. Functionally, up-regulation of inhibitory receptors in immune cells before stimulation might increase their activation thresholds and participate in immune escape mechanisms.

摘要

非经典的I类人类白细胞抗原(HLA)HLA-G是一种参与免疫耐受和免疫逃逸的抑制性分子。HLA-G通过与抑制性受体ILT2、ILT4和KIR2DL4相互作用发挥其抑制功能,这些受体在自然杀伤细胞(NK)、T细胞和抗原呈递细胞中差异表达。表达HLA-G的细胞与其受体表达细胞常彼此相邻,但导致这种共定位的机制仍不清楚。我们报告,在抗原呈递细胞、NK细胞和T细胞中,HLA-G可上调ILT2、ILT3、ILT4和KIR2DL4的表达。由于这种上调似乎不需要抗原共刺激,它可能先于免疫反应发生。在功能上,刺激前免疫细胞中抑制性受体的上调可能会提高其激活阈值,并参与免疫逃逸机制。

相似文献

1
HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.HLA-G可上调抗原呈递细胞、自然杀伤细胞和T细胞中的ILT2、ILT3、ILT4和KIR2DL4。
FASEB J. 2005 Apr;19(6):662-4. doi: 10.1096/fj.04-1617fje. Epub 2005 Jan 24.
2
Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.人类抑制性受体免疫球蛋白样转录物2(ILT2)和ILT4与CD8竞争结合MHC I类分子,并优先结合HLA - G。
Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8856-61. doi: 10.1073/pnas.1431057100. Epub 2003 Jul 9.
3
HLA-G modulates immune responses by diverse receptor interactions.HLA-G通过多种受体相互作用调节免疫反应。
Semin Cancer Biol. 2003 Oct;13(5):317-23. doi: 10.1016/s1044-579x(03)00022-1.
4
Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.单核细胞衍生的HLA-G作为自体CD4 T细胞活化的强力抑制剂,在体外和体内均被β干扰素上调:多发性硬化症治疗的理论依据。
J Neuroimmunol. 2005 Feb;159(1-2):155-64. doi: 10.1016/j.jneuroim.2004.09.016. Epub 2004 Dec 28.
5
HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.HLA I类分子通过抑制性受体ILT2/CD85j调节靶细胞、病毒产物或未成熟树突状细胞在自然杀伤细胞中诱导产生的γ干扰素。
J Immunol. 2008 Aug 15;181(4):2368-81. doi: 10.4049/jimmunol.181.4.2368.
6
Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis.通过 RNAi 抑制 HLA-G 的表达可消除绒毛外滋养层细胞系 TEV-1 对 NK 溶解的抗性。
Placenta. 2010 Jun;31(6):519-27. doi: 10.1016/j.placenta.2010.03.008. Epub 2010 Apr 28.
7
Residues Met76 and Gln79 in HLA-G alpha1 domain involve in KIR2DL4 recognition.HLA-G α1结构域中的甲硫氨酸76和谷氨酰胺79残基参与KIR2DL4识别。
Cell Res. 2005 Mar;15(3):176-82. doi: 10.1038/sj.cr.7290283.
8
Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.白细胞介素-15诱导人胸腺早期前体细胞自然杀伤细胞成熟:CD94/NKG2-A作为唯一的HLA I类特异性抑制性受体的选择性表达。
Eur J Immunol. 1997 Jun;27(6):1374-80. doi: 10.1002/eji.1830270612.
9
Possible roles of KIR2DL4 expression on uNK cells in human pregnancy.KIR2DL4在人妊娠子宫自然杀伤细胞上的表达可能发挥的作用。
Am J Reprod Immunol. 2007 Apr;57(4):233-42. doi: 10.1111/j.1600-0897.2007.00469.x.
10
Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.人乳腺癌中非经典I类组织相容性HLA - G抗原的特异性激活及ILT2抑制性受体的表达
J Pathol. 2002 Mar;196(3):266-74. doi: 10.1002/path.1039.

引用本文的文献

1
Emerging roles of KIR2DL4 in cancer immunotherapy.KIR2DL4在癌症免疫治疗中的新作用。
Breast Cancer. 2025 Jun 23. doi: 10.1007/s12282-025-01738-y.
2
Natural killer cells: the immune frontline against circulating tumor cells.自然杀伤细胞:抵御循环肿瘤细胞的免疫前线。
J Exp Clin Cancer Res. 2025 Apr 10;44(1):118. doi: 10.1186/s13046-025-03375-x.
3
LILRB1-HLA-G axis defines a checkpoint driving natural killer cell exhaustion in tuberculosis.LILRB1-HLA-G 轴定义了一个检查点,驱动结核分枝杆菌自然杀伤细胞衰竭。
EMBO Mol Med. 2024 Aug;16(8):1755-1790. doi: 10.1038/s44321-024-00106-1. Epub 2024 Jul 19.
4
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.LILRB4 免疫疗法检查点:结构、机制和疾病靶点。
Biomolecules. 2024 Feb 4;14(2):187. doi: 10.3390/biom14020187.
5
Analysis of HLA-G 14 bp Insertion/Deletion Polymorphism and HLA-G, ILT2 and ILT4 Expression in Head and Neck Squamous Cell Carcinoma Patients.头颈部鳞状细胞癌患者中HLA-G 14bp插入/缺失多态性及HLA-G、ILT2和ILT4表达的分析
Diseases. 2024 Feb 8;12(2):34. doi: 10.3390/diseases12020034.
6
Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects.利用 HLA-G 在癌症治疗中的潜力:进展、挑战与展望。
J Transl Med. 2024 Feb 3;22(1):130. doi: 10.1186/s12967-024-04938-w.
7
Human leukocyte immunoglobulin-like receptors in health and disease.人类白细胞免疫球蛋白样受体在健康与疾病中的作用。
Front Immunol. 2023 Nov 13;14:1282874. doi: 10.3389/fimmu.2023.1282874. eCollection 2023.
8
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.靶向 LILRB1 在癌症固有和适应性免疫检查点治疗中的研究进展。
Front Immunol. 2023 Sep 13;14:1240275. doi: 10.3389/fimmu.2023.1240275. eCollection 2023.
9
The Molecular Mechanisms of HLA-G Regulatory Function on Immune Cells during Early Pregnancy.HLA-G 对妊娠早期免疫细胞的调控作用的分子机制。
Biomolecules. 2023 Aug 3;13(8):1213. doi: 10.3390/biom13081213.
10
Alterations of natural killer cells activatory molecules phenotype and function in mothers of ASD children: a pilot study.自闭症谱系障碍儿童母亲自然杀伤细胞激活分子表型和功能的改变:一项初步研究。
Front Immunol. 2023 Jul 20;14:1190925. doi: 10.3389/fimmu.2023.1190925. eCollection 2023.